Seegene

Seegene (096530) Q2 2025 Earnings Shock: What Investors Need to Know

by

Seegene’s Q2 Earnings Disappoint, Triggering Investor Concerns Seegene’s preliminary Q2 2025 earnings, released on August 8, 2025, sent shockwaves through the market. While revenue met expectations, operating profit significantly underperformed. This article delves into the factors contributing to Seegene’s disappointing results and provides insights for investors. 1. Seegene Q2 2025: What Happened? Seegene reported revenue … Read more

Seegene Announces 896 Treasury Stock Disposal: Impact on Stock Price?

by

Seegene Disposes of 896 Treasury Shares: What Should Investors Do? Seegene has announced the disposal of 896 treasury shares. What does this news mean for investors? From short-term stock price fluctuations to long-term investment strategies, this article analyzes the background of Seegene’s treasury stock disposal and its impact, and presents an action plan for successful … Read more

Seegene Announces Dividend After Q1 Turnaround: Should You Invest?

by

Seegene Returns to Profit and Declares a Dividend: Is it Time to Invest? Seegene, a leading molecular diagnostics company, announced a return to profitability in Q1 2025 along with a KRW 200 dividend per share. This surprise announcement has caught the attention of investors. This article delves into the rationale behind Seegene’s dividend decision and … Read more